A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
Main Authors: | Y-F Chen, P Jobanputra, P Barton, S Jowett, S Bryan, W Clark, A Fry-Smith, A Burls |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2006-11-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta10420 |
Similar Items
-
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
by: P. Jobanputra, et al.
Published: (2002-01-01) -
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
by: K Malottki, et al.
Published: (2011-03-01) -
Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
by: Martínez-Pérez Rosalía, et al.
Published: (2011-11-01) -
Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis Hepatotoxicidad recurrente asociada a etanercept y adalimumab pero no a infliximab en una paciente con artritis reumatoide
by: José Carlos Titos-Arcos, et al.
Published: (2012-05-01) -
Avaliação econômica das anticitocinas adalimumabe, etanercepte e infliximabe no tratamento da artrite reumatoide no Estado do Paraná Economic evaluation of anticitokines adalimumab, etanercept and infliximab for treatment of rheumatoid arthritis in Paraná State, Brazil
by: Rafael Venson, et al.
Published: (2011-01-01)